Reckitt Benkiser (Bangladesh) Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Reckitt Benkiser (Bangladesh) Ltd with three other
pharmaceutical manufacturers in Asia:
Gufic Biosciences Ltd
of INDIA
(2019
sales of 3.51 billion Indian Rupees [US$47.70 million]
of which 100%
was Pharmaceuticals),
Center Laboratories Inc
of TAIWAN
(1.44 billion Taiwanese Dollars [US$49.57 million]
of which 53%
was Domestic Westen Medicine), and
Aarey Drugs and Pharmaceuticals Ltd
which is
based in INDIA
(3.55 billion Indian Rupees [US$48.24 million]
).
Sales Analysis.
Reckitt Benkiser (Bangladesh) Ltd reported sales of 4.13 billion Bangladeshi Taka (US$48.69 million)
for the
year ending
December of 2019.
This
represents
an
increase of 6.0%
versus 2018, when the company's sales were 3.89 billion Bangladeshi Taka.
Sales at Reckitt Benkiser (Bangladesh) Ltd have increased during each of the previous five years
(and since 2014, sales have increased a total of 55%).